Evidence map›Paper›PMID 34852001›Full record

ArticlePloS one2021

Peer- and community-led responses to HIV: A scoping review.

George Ayala, Laurel Sprague, L Leigh-Ann van der Merwe, Ruth Morgan Thomas, Judy Chang, Sonya Arreola, Sara L M Davis, Aditia Taslim, Keith Mienies, Alessandra Nilo and 4 more

Open access · goldAbstract readScoping Review
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 3 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 5 countries.

George AyalaMPact Global Action for Gay Men's Health and Rights, Oakland, CA, United States of America.ORCID 0000-0003-2255-7582
Laurel SpragueJoint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.ORCID 0000-0003-4578-7217
L Leigh-Ann van der MerweSocial, Health and Empowerment Feminist Collective of Transgender Women in Africa, East London, South Africa.
Ruth Morgan ThomasGlobal Network of Sex Work Projects, Edinburgh, Scotland.
Judy ChangInternational Network of People Who Use Drugs, London, United Kingdom.
Sonya ArreolaMPact Global Action for Gay Men's Health and Rights, Oakland, CA, United States of America.ORCID 0000-0003-3485-4760
Sara L M DavisGraduate Institute, Geneva, Switzerland.ORCID 0000-0003-0914-3529
Aditia TaslimRumah Cemara, Bandung, Indonesia.
Keith MieniesThe Global Fund to Fight AIDS, Tuberculosis, and Malaria, Geneva, Switzerland.
Alessandra NiloGestos-HIV, Communication and Gender, Recife, Brazil.
Lillian MworekoInternational Community of Women Living with HIV Eastern Africa, Kampala, Uganda.
Felicita HikuamAIDS and Rights Alliance for Southern Africa, Windhoek, Namibia.
Carlos Garcia de Leon MorenoJoint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.
José Antonio Izazola-LiceaJoint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.ORCID 0000-0002-3658-2570
Joint United Nations Programme on HIV/AIDS · CHAlameda County Public Health Department · USGender Studies · CZGlobal Fund to Fight AIDS, Tuberculosis and Malaria · CHGraduate Institute of International and Development Studies · CHInternational Community of Women Living with HIV · UG

Funding

Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
NIMH NIH HHS R25 MH067127
6 · The paper itself

Abstract

introductionIn June 2021, United Nations (UN) Member States committed to ambitious targets for scaling up community-led responses by 2025 toward meeting the goals of ending the AIDS epidemic by 2030. These targets build on UN Member States 2016 commitments to ensure that 30% of HIV testing and treatment programmes are community-led by 2030. At its current pace, the world is not likely to meet these nor other global HIV targets, as evidenced by current epidemiologic trends. The COVID-19 pandemic threatens to further slow momentum made to date. The purpose of this paper is to review available evidence on the comparative advantages of community-led HIV responses that can better inform policy making towards getting the world back on track.

methodsWe conducted a scoping review to gather available evidence on peer- and community-led HIV responses. Using UNAIDS' definition of 'community-led' and following PRISMA guidelines, we searched peer-reviewed literature published from January 1982 through September 2020. We limited our search to articles reporting findings from randomized controlled trials as well as from quasi-experimental, prospective, pre/post-test evaluation, and cross-sectional study designs. The overall goals of this scoping review were to gather available evidence on community-led responses and their impact on HIV outcomes, and to identify key concepts that can be used to quickly inform policy, practice, and research.

findingsOur initial search yielded 279 records. After screening for relevance and conducting cross-validation, 48 articles were selected. Most studies took place in the global south (n = 27) and a third (n = 17) involved youth. Sixty-five percent of articles (n = 31) described the comparative advantage of peer- and community-led direct services, e.g., prevention and education (n = 23) testing, care, and treatment programs (n = 8). We identified more than 40 beneficial outcomes linked to a range of peer- and community-led HIV activities. They include improved HIV-related knowledge, attitudes, intentions, self-efficacy, risk behaviours, risk appraisals, health literacy, adherence, and viral suppression. Ten studies reported improvements in HIV service access, quality, linkage, utilization, and retention resulting from peer- or community-led programs or initiatives. Three studies reported structural level changes, including positive influences on clinic wait times, treatment stockouts, service coverage, and exclusionary practices. CONCLUSIONS AND RECOMMENDATIONS: Findings from our scoping review underscore the comparative advantage of peer- and community-led HIV responses. Specifically, the evidence from the published literature leads us to recommend, where possible, that prevention programs, especially those intended for people living with and disproportionately affected by HIV, be peer- and community-led. In addition, treatment services should strive to integrate specific peer- and community-led components informed by differentiated care models. Future research is needed and should focus on generating additional quantitative evidence on cost effectiveness and on the synergistic effects of bundling two or more peer- and community-led interventions.

Indexed as

Delivery of Health CareHealth Knowledge, Attitudes, PracticeHealth LiteracyHIV InfectionsHumansMedication AdherencePeer GroupRisk-TakingSelf EfficacyUnited Nations

Identifiers

PMID34852001
PMCPMC8635382
OpenAlexW3215676146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.